Excellent care – Human to Human
Our pledge, Committed to Life, underlines our mission: To save lives and improve patients’ health and quality of life. Our employees put this promise into practice every day – whether in direct contact with patients or behind the scenes in administration and production.
People are at the heart of our business activities. We accompany patients through various stages of their lives – sometimes even on a lifelong basis. In doing so, we treat them with respect, as equals, and with a deep understanding of their needs.
We want to promote access to high-quality healthcare and medicine. To this end, we focus on innovative and digital treatment options that enable us to reach even more people.
With the commitment they demonstrate day and night, our employees are a key factor in our success. We want to offer them the best possible working environment, where they can develop and reach their full potential.
Our Outreach
We treated
~ 26 m
patients in our hospitals in 2024.
We served
450 m
patients with our healthcare products in 2024.
The Human Dimension of our Sustainability Framework encompasses these focus topics:
Patient centricity at Fresenius means prioritizing multifaceted patient needs and experiences by providing holistic care through market-leading medical products and services – in inpatient and outpatient settings.
Every year, millions of people entrust us with their most precious asset: their health. With our expertise, we accompany our patients through health and illness: from human to human.
We set out to make our treatments more successful by providing high-quality care. This can help to shorten our patients’ hospital stays, enhance their quality of life – and improve patient satisfaction.
➔ Read more in our Sustainability Statement.
Digitalization plays a crucial role in shaping personalized and efficient processes in our hospitals as well as in the use of our products. We continuously digitize existing processes and introduce new digital workflows. Further, we leverage the capabilities of Artificial Intelligence to enhance the patient experience and expand treatment options, while ensuring its responsible use in accordance with ethical standards, data privacy regulations, and transparency principles.
➔ Read more in our Sustainability Statement.
We strive to provide affordable, high-quality products and services that are accessible and enable significant savings to healthcare systems.
Our range of products and services includes the services of a broad network of clinics as well as high-quality pharmaceuticals and medical devices. We also use digitalization opportunities and develop new forms of therapy. In this way, we aim to reach as many people as possible with our healthcare services and products.
We are dedicated to advancing global health by prioritizing patient well-being and empowering employees. Our growing portfolio includes pharmaceuticals – generics and biosimilars – that offer cost-effective alternatives to originator drugs, and our MedTech and Nutrition products that establish a solid foundation for patient care and recovery.
Ensuring that our products are available is vital to patient care. We continuously invest in our global manufacturing network to maintain a reliable and resilient supply of life-saving therapies. By strengthening our supply infrastructure, we help to prevent disruptions and enhance healthcare delivery worldwide.
➔ Read more in our Sustainability Statement.
Strengthening our purpose-driven performance culture to attract, develop, and retain a motivated workforce is a key priority – because our employees are the foundation of delivering excellent medical care.
Committed to Life – our nearly 180,000 employees put this promise into practice every day: whether in direct contact with patients, relatives, and business partners or behind the scenes in administration and production.
As an employer, it is our responsibility to provide good and safe working conditions for our employees. We seek direct interaction with our employees – because their wide variety of experiences and views help us to constantly improve. Providing our employees with the best possible support in the various phases of their careers while also promoting their commitment and development is very important to us.
Our Team
179884
people were employed by the Fresenius Group in 2024.
41.1
– was the average age of our employees in 2024.
Sustainability Insights
Explore our stories to learn what sustainability looks like in our daily operations:
-
The smart future of healthcare
Artificial Intelligence is driving the healthcare industry – and Fresenius is leveraging its capabilities to enhance the patient experience and broaden treatment options.
-
Nutrition – the key to human health
“You are what you eat.” This familiar saying highlights the importance of nutrition for human health. Food is our source of energy, nutrients, vitamins and trace elements. These ingredients provide us with everything we need to stay healthy and to recover when we are sick.
-
Relieving the pressure in the ED
Overcrowded, and really long waiting times – being in the emergency department (ED) sometimes feels worse than the injury or sickness itself. At Quirónsalud, we are continuously working to improve this experience for everyone involved.
-
Angels for Change
Fresenius Kabi USA received the Drug Shortage Guardian Award 2024 from the Angels for Change in May 2024. The mission of this organization is to look after patients during drug shortages.
-
A strong team for the future
What would a hospital actually be without nursing staff? There’s a clear answer: the hospital would shut down. Helios is the largest hospital operator in Germany with more than 80 clinics, and has developed an array of ideas to attract the best candidates.
-
Virtual reality training at Fresenius Kabi
With the introduction of virtual reality training at Fresenius Kabi, new employees in cleanrooms are able to familiarize themselves with the cleanroom setting in a realistic way before physically entering one.
Our Sustainability Framework
Our mission is to save and improve human lives. We focus on opportunities that arise from sustainable business practices and use them to drive measurable progress. This approach is built on a unique corporate legacy that spans more than a century. We are guided by strong principles and a clear direction for the future.
Our Sustainability Framework guides our daily actions and shapes how we integrate sustainability into our business.
We focus on three core dimensions:
“For us, sustainability is not just a buzzword. It's our responsibility and our strength. It makes us competitive and resilient, ensuring our success. Both today and tomorrow.”
Dr. Michael Moser, Member of the Fresenius Management Board, responsible for Legal, Compliance, Risk Management, Sustainability, Human Resources, Corporate Audit and Vamed
Our Goals and Progress
Since we can only improve what we understand and control, we have set ourselves goals along our business activities – for the Group as a whole and for the individual operating companies.
At Fresenius, sustainability is an important responsibility of the Management Board: As a key component of our business strategy, sustainability targets are also included in the variable compensation of the Management Board.
Our Sustainability Governance
Effective governance is essential for us to understand and actively manage our activities. It provides the structure and accountability needed to ensure that our sustainability ambitions are not just aspirations, but actions. Through an integrated approach, we turn isolated initiatives into meaningful progress.
Clear ownership and strong collaboration
At Fresenius, overall responsibility for sustainability lies with the Fresenius Management Board member responsible for Legal, Compliance, Risk Management, Sustainability, Human Resources, Corporate Audit and Fresenius Vamed.
The Group Sustainability function serves as the central competence center for sustainability across the Group. It monitors regulatory developments, identifies material topics, defines strategic priorities and opportunities to drive implementation of our Sustainability Framework. It supports the Group-wide rollout of sustainability initiatives. It is also responsible for sustainability-related internal and external stakeholder communication and, together with Global Accounting, for non-financial reporting.
The Group Sustainability Committee defines the company-wide approach, monitors progress, and oversees its implementation – both overall and across the individual focus topics. Dedicated working groups throughout the organization drive these topics forward and ensure their operational execution.
The Management Board and the Supervisory Board review the progress and the results of the sustainability management across the Group.
"We focus our sustainability efforts where they create the greatest impact for people, the planet, and our business. With clear goals and close monitoring, we systematically embed sustainability across every part of our operations."
Sarah Tix, Head of Group Sustainability, Fresenius Group
Our Sustainability Advisory Board
Fresenius has appointed an independent Sustainability Advisory Board. Four leading international experts from science, business, and consulting are supporting us in further developing our related activities.
Image from left to right: Fabian Kienbaum, Dr. Fiona Adshead, Dr. Michael Moser (Member of the Management Board), Anahita Thoms (Chair) and Prof. Dr. Judith Walls.
-
Sustainability Perspectives
Gain insights into our recent activities and meet the colleagues driving our efforts.
Meeting of the Sustainability Advisory Board at Quirónsalud: Human-Centered Care in Focus
How digital innovation and value-based healthcare are transforming the provision of healthcare services and enabling patient-centered, sustainable solutions was the focus of Fresenius’ Sustainability Advisory Board meeting held in Madrid in June 2025.
-
Sustainability Perspectives
Gain insights into our recent activities and meet the colleagues driving our efforts.
Sustainability at Fresenius: Five Questions for Sarah Tix, Head of Group Sustainability
"In our view, sustainability management represents a real opportunity and is essential for securing the resilience, competitiveness, and long-term success of companies."
-
Sustainability Perspectives
Gain insights into our recent activities and meet the colleagues driving our efforts.
Meeting of the Sustainability Advisory Board at Fresenius Kabi: Driving Sustainability in Manufacturing
At the first SAB meeting of 2025, held at the Fresenius Kabi production site in Friedberg, Germany, a range of topics related to advancing our sustainability efforts, especially in manufacturing, were discussed – from water management to human rights due diligence.
-
Sustainability Perspectives
Gain insights into our recent activities and meet the colleagues driving our efforts.
Climate Protection: Three questions for Mapi Henríquez de Armas, Director Sustainability at Quirónsalud
"While adapting to climate change is managed at a local level, we have set global emission reduction targets that help us to meet related expectations and to coordinate our efforts."
You would like to learn more about the specific sustainability activities of our operating companies? Have a look at their dedicated websites:
Members of the Management Board of Fresenius Management SE (General Partner):
Michael Sen, 56, became Chairman of the Management Board of Fresenius (equivalent to President and CEO) on October 1, 2022. He joined Fresenius in April 2021 as Chairman of the Management Board of Fresenius Kabi. Before joining Fresenius Kabi, Michael Sen was a member of the Management Board of Siemens AG, where he was responsible for the healthcare business Siemens Healthineers and for Siemens’ energy business. Prior to that, he was Chief Financial Officer of E.ON SE. At the start of his professional career, Michael Sen completed an apprenticeship at Siemens in Berlin and then studied business administration at the Technical University of Berlin.
Pierluigi Antonelli, 58, joined the Management Board of Fresenius in March 2023 with responsibility for Fresenius Kabi. In his previous role since 2019, he was the CEO of Angelini Pharma, a company of the Italian Angelini Group specializing in brain health and consumer health. Prior to that, he held senior leadership positions at Novartis Oncology, Sandoz, Merck & Co. and Bristol Myers Squibb in the United States and across Europe.
Sara Hennicken (45) was appointed CFO of Fresenius as of September 1, 2022. She joined the Group in 2019 as Senior Vice President Global Treasury & Corporate Finance for Fresenius and Fresenius Medical Care. Previously, she spent 14 years in investment banking, including nine years at Deutsche Bank, lastly as Managing Director and Senior Client Executive in Corporate Finance Coverage before moving to Fresenius. Between 2005 and 2010 she worked for Citigroup in Frankfurt and London. Sara Hennicken studied economics in Germany and in the United States.
Robert Möller, 58, joined the Management Board of Fresenius in September 2023 with responsibility for Fresenius Helios. Robert Möller has been CEO of Helios Kliniken GmbH since 2022. He joined Helios in 2014, where he held the position of Clinic Managing Director at Helios Hanseklinikum Stralsund until 2017. After a short time away, he returned to Helios in 2019 and took over the management of various regions. Möller studied human medicine at the University of Hamburg and practiced as a specialist for internal medicine. After various medical positions and a part-time master's degree in health care management, he switched to hospital management while continuing to work as a physician.
Michael Moser (49) joined the Management Board of Fresenius in July 2023. He is responsible for Legal, Compliance, Risk Management, Sustainability, Human Resources, Corporate Audit and transformation of the Vamed businesses. After starting his career at Baker McKenzie, he joined E.ON SE in 2008. During this time, he inter alia became member of the Management Board of the stock listed company ENEVA in Brazil, steered the listing of Uniper and served as Deputy CEO and CFO of Enerjisa, the stock listed leading energy company in Turkey. He has received university degrees in law and business economics in Germany, USA, UK, Switzerland and China.
Contact
Fresenius SE & Co. KGaA
Else-Kröner-Str. 1
61352 Bad Homburg v.d.H.
Germany
board@fresenius.com
In 2024, Fresenius established the Sustainability Advisory Board (SAB), an external body of renowned experts. Leveraging their expertise, SAB members support the further development of our sustainability efforts both collectively and individually by engaging with relevant experts and executives from different parts of our organization on specific matters within their areas of specialization.
Members
Anahita Thoms (Chair)
The head of Baker McKenzie’s international trade practice in Germany is a member of the EMEA Steering Committee for Compliance & Investigations and Global Lead Sustainability Partner for the Industrials, Manufacturing, and Transportation industry group. She is a member of the National Committee of UNICEF Deutschland and of the Board of Directors of Atlantik-Brücke. She was also a member of the German government’s Sustainable Finance Advisory Board and the ABA International Human Rights Steering Committee.
Dr. Fiona Adshead
The former Deputy Chief Medical Officer of the UK Government is a leading expert on sustainability and health. She is currently Chair of the Sustainable Healthcare Coalition, an organization that brings together partners to promote sustainable healthcare.
Fabian Kienbaum
The managing partner at Kienbaum focuses on advising family businesses on governance and succession issues. He is also the author of publications on leadership and modern working environments.
Prof. Dr. Judith Walls
The Chair of Sustainability Management and Director of the Institute for Economy and Ecology at the University of St. Gallen conducts research at the interface of economy and ecological sustainability.
Updates from the Sustainability Advisory Board
In regular meetings, our executives, experts, and members of the Sustainability Advisory Board come together to discuss key questions related to the focus areas of our Sustainability Framework, its implementation, and further development. Explore articles below to learn more.
-
Advancing human-centered care
How digital innovation and value-based healthcare are transforming the provision of healthcare services and enabling patient-centered, sustainable solutions was the focus of Fresenius’ Sustainability Advisory Board meeting held in Madrid in June 2025.
-
Driving Sustainability in Manufacturing
At the first SAB meeting of 2025, held at the Fresenius Kabi production site in Friedberg, Germany, a range of topics related to advancing our sustainability efforts, especially in manufacturing, were discussed – from water management to human rights due diligence.
Fresenius is integrated into a diverse network of interest groups. From this exchange, we gain valuable insights that help us to continuously improve the management of material topics and reporting.
We engage with our stakeholders through a variety of channels. The corporate functions at Fresenius primarily focus on stakeholders who are relevant to the Group as a whole. The Operating Companies actively engage with patients, employees, customers, and regulatory authorities, among others.
For the integration of potentially affected stakeholders in our operating activities, we consider, for example, findings from existing due diligence processes and risk assessments in quality, internal employee satisfaction surveys, dialogs with employee representatives and works councils, patient and customer surveys.
An important element of our stakeholder dialogs is our active participation in industry and interest groups, as well as our exchange with business partners. Our employees contribute their expertise to national and international bodies, committees, and associations.
We are committed to observing the codes and principles associated with our membership in various associations. In addition, we disclose all contributions made to healthcare professionals in the companies of Fresenius in accordance with the applicable disclosure requirements.
➔ You can find more information about our collaborations and social activities in the Data & Reporting Hub.
Sustainability Perspectives
Gain insight into Fresenius' recent sustainability activities and meet the dedicated colleagues contributing to our global efforts:
-
Five questions for Sarah Tix, Head of Group Sustainability, Fresenius Group
"In our view, sustainability management represents a real opportunity and is essential for securing the resilience, competitiveness, and long-term success of companies."
-
Meeting of the Sustainability Advisory Board at Quirónsalud
How digital innovation and value-based healthcare are transforming the provision of healthcare services and enabling patient-centered, sustainable solutions was the focus of Fresenius’ Sustainability Advisory Board meeting held in Madrid in June 2025.
-
Three questions for Mapi Henríquez de Armas, Director Sustainability at Quirónsalud
"While adapting to climate change is managed at a local level, we have set global emission reduction targets that help us to meet related expectations and to coordinate our efforts."
-
Meeting of the Sustainability Advisory Board at Fresenius Kabi
At the first SAB meeting of 2025, held at the Fresenius Kabi production site in Friedberg, Germany, a range of topics related to advancing our sustainability efforts, especially in manufacturing, were discussed – from water management to human rights due diligence.
With our reporting and communication formats, we provide comprehensive information on our Sustainability Framework and the management of material topics. Group-wide policies enable consistent integration of sustainability considerations in daily business operations.
In our rating overview, we present the latest scores from relevant ESG rating agencies.
Publications and Policies
In our annual sustainability reporting, we disclose required regulatory information regarding our material sustainability topics. In addition, we publish our Sustainability Highlights Magazine once a year, providing an overview of our related activities.
Sustainability Statement 2024
in accordance with the European Sustainability Reporting Standards
Our policies provide employees and business partners with clear guidance on our approach to responsible business conduct and sustainability. Among the relevant internal documents are:
Fresenius Group Code of Coduct
Rating overview
ESG rating agencies regularly evaluate and review Fresenius' sustainability performance. In doing so, they focus on different aspects across the areas of Environment, Social, and Governance (ESG).
A close dialog with our stakeholders on these topics is very important to us. We are actively working to enhance transparency on relevant topics. This is reflected in consistently good rating results.
*The use by FRESENIUS SE & CO. KGAA of any MSCI ESG RESEARCH LLC or its affiliates (“MSCI”) data, and the use of MSCI logos, trademarks, service marks or index names herein, do not constitute a sponsorship, endorsement, recommendation, or promotion of FRESENIUS SE & CO. KGAA by MSCI. MSCI services and data are the property of MSCI or its information providers, and are provided ‘as-is’ and without warranty. MSCI names and logos are trademarks or service marks of MSCI.
*Copyright ©2025 Morningstar Sustainalytics. All rights reserved. The information, data, analyses and opinions contained herein: (1) includes the proprietary information of Sustainalytics and/or its content providers; (2) may not be copied or redistributed except as specifically authorized; (3) do not constitute investment advice nor an endorsement of any product, project, investment strategy or consideration of any particular environmental, social or governance related issues as part of any investment strategy; (4) are provided solely for informational purposes; and (5) are not warranted to be complete, accurate or timely. The ESG-related information, methodologies, tool, ratings, data, and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted. Neither Morningstar Inc., Sustainalytics, nor their content providers accept any liability for the use of the information, for actions of third parties in respect to the information, nor are responsible for any trading decisions, damages or other losses related to the information or its use. The use of the data is subject to conditions available at https://www.sustainalytics.com/legal-disclaimers.
September 17, 2025
virtual
SdK Anleger Forum
Event for retail investors (German only)
